nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—ABCG2—Topotecan—cervical cancer	0.68	1	CbGbCtD
Clofarabine—POLA1—uterine cervix—cervical cancer	0.00683	0.0382	CbGeAlD
Clofarabine—Mucosal inflammation—Topotecan—cervical cancer	0.00659	0.0513	CcSEcCtD
Clofarabine—RRM2—uterine cervix—cervical cancer	0.00653	0.0365	CbGeAlD
Clofarabine—POLA1—decidua—cervical cancer	0.00651	0.0364	CbGeAlD
Clofarabine—RRM2—decidua—cervical cancer	0.00622	0.0348	CbGeAlD
Clofarabine—POLA1—endometrium—cervical cancer	0.00618	0.0345	CbGeAlD
Clofarabine—RRM2—renal system—cervical cancer	0.00611	0.0341	CbGeAlD
Clofarabine—Febrile neutropenia—Topotecan—cervical cancer	0.00606	0.0472	CcSEcCtD
Clofarabine—POLA1—mammalian vulva—cervical cancer	0.00598	0.0334	CbGeAlD
Clofarabine—RRM2—endometrium—cervical cancer	0.0059	0.033	CbGeAlD
Clofarabine—RRM2—mammalian vulva—cervical cancer	0.00571	0.0319	CbGeAlD
Clofarabine—RRM2—uterus—cervical cancer	0.00544	0.0304	CbGeAlD
Clofarabine—RRM1—uterine cervix—cervical cancer	0.00542	0.0303	CbGeAlD
Clofarabine—RRM1—decidua—cervical cancer	0.00517	0.0289	CbGeAlD
Clofarabine—RRM1—renal system—cervical cancer	0.00507	0.0284	CbGeAlD
Clofarabine—RRM1—endometrium—cervical cancer	0.0049	0.0274	CbGeAlD
Clofarabine—RRM2—female reproductive system—cervical cancer	0.00489	0.0273	CbGeAlD
Clofarabine—Pleural effusion—Topotecan—cervical cancer	0.00476	0.0371	CcSEcCtD
Clofarabine—Rash erythematous—Topotecan—cervical cancer	0.00476	0.0371	CcSEcCtD
Clofarabine—RRM1—mammalian vulva—cervical cancer	0.00474	0.0265	CbGeAlD
Clofarabine—POLA1—female gonad—cervical cancer	0.00466	0.026	CbGeAlD
Clofarabine—POLA1—vagina—cervical cancer	0.00463	0.0259	CbGeAlD
Clofarabine—RRM1—uterus—cervical cancer	0.00452	0.0253	CbGeAlD
Clofarabine—RRM2—female gonad—cervical cancer	0.00445	0.0249	CbGeAlD
Clofarabine—RRM2—vagina—cervical cancer	0.00442	0.0247	CbGeAlD
Clofarabine—DCK—uterine cervix—cervical cancer	0.00421	0.0235	CbGeAlD
Clofarabine—RRM1—female reproductive system—cervical cancer	0.00406	0.0227	CbGeAlD
Clofarabine—DCK—decidua—cervical cancer	0.00401	0.0224	CbGeAlD
Clofarabine—Hyperbilirubinaemia—Topotecan—cervical cancer	0.00401	0.0312	CcSEcCtD
Clofarabine—Blood bilirubin increased—Topotecan—cervical cancer	0.00386	0.03	CcSEcCtD
Clofarabine—DCK—endometrium—cervical cancer	0.00381	0.0213	CbGeAlD
Clofarabine—Bone pain—Topotecan—cervical cancer	0.00381	0.0297	CcSEcCtD
Clofarabine—Respiratory failure—Topotecan—cervical cancer	0.00371	0.0289	CcSEcCtD
Clofarabine—RRM1—female gonad—cervical cancer	0.0037	0.0207	CbGeAlD
Clofarabine—DCK—mammalian vulva—cervical cancer	0.00368	0.0206	CbGeAlD
Clofarabine—RRM1—vagina—cervical cancer	0.00367	0.0205	CbGeAlD
Clofarabine—DCK—uterus—cervical cancer	0.00351	0.0196	CbGeAlD
Clofarabine—Colitis—Topotecan—cervical cancer	0.0035	0.0273	CcSEcCtD
Clofarabine—Rash maculo-papular—Topotecan—cervical cancer	0.00332	0.0258	CcSEcCtD
Clofarabine—Neoplasm—Topotecan—cervical cancer	0.0033	0.0257	CcSEcCtD
Clofarabine—Sepsis—Topotecan—cervical cancer	0.00317	0.0247	CcSEcCtD
Clofarabine—DCK—female reproductive system—cervical cancer	0.00316	0.0176	CbGeAlD
Clofarabine—POLA1—lymph node—cervical cancer	0.00299	0.0167	CbGeAlD
Clofarabine—DCK—female gonad—cervical cancer	0.00287	0.0161	CbGeAlD
Clofarabine—RRM2—lymph node—cervical cancer	0.00286	0.016	CbGeAlD
Clofarabine—DCK—vagina—cervical cancer	0.00285	0.016	CbGeAlD
Clofarabine—Lethargy—Topotecan—cervical cancer	0.0027	0.021	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.00238	0.0186	CcSEcCtD
Clofarabine—RRM1—lymph node—cervical cancer	0.00238	0.0133	CbGeAlD
Clofarabine—ABCG2—uterine cervix—cervical cancer	0.00235	0.0131	CbGeAlD
Clofarabine—Alanine aminotransferase increased—Topotecan—cervical cancer	0.00234	0.0182	CcSEcCtD
Clofarabine—ABCG2—decidua—cervical cancer	0.00224	0.0125	CbGeAlD
Clofarabine—Pancytopenia—Topotecan—cervical cancer	0.00217	0.0169	CcSEcCtD
Clofarabine—Neutropenia—Topotecan—cervical cancer	0.00214	0.0167	CcSEcCtD
Clofarabine—ABCG2—endometrium—cervical cancer	0.00213	0.0119	CbGeAlD
Clofarabine—ABCG2—mammalian vulva—cervical cancer	0.00206	0.0115	CbGeAlD
Clofarabine—Pneumonia—Topotecan—cervical cancer	0.00205	0.016	CcSEcCtD
Clofarabine—Infestation NOS—Topotecan—cervical cancer	0.00204	0.0159	CcSEcCtD
Clofarabine—Infestation—Topotecan—cervical cancer	0.00204	0.0159	CcSEcCtD
Clofarabine—Neuropathy peripheral—Topotecan—cervical cancer	0.002	0.0156	CcSEcCtD
Clofarabine—Stomatitis—Topotecan—cervical cancer	0.00199	0.0155	CcSEcCtD
Clofarabine—ABCG2—uterus—cervical cancer	0.00196	0.0109	CbGeAlD
Clofarabine—Hepatobiliary disease—Topotecan—cervical cancer	0.00193	0.015	CcSEcCtD
Clofarabine—Epistaxis—Topotecan—cervical cancer	0.00192	0.015	CcSEcCtD
Clofarabine—DCK—lymph node—cervical cancer	0.00185	0.0103	CbGeAlD
Clofarabine—Haemoglobin—Topotecan—cervical cancer	0.00184	0.0143	CcSEcCtD
Clofarabine—Haemorrhage—Topotecan—cervical cancer	0.00183	0.0143	CcSEcCtD
Clofarabine—Angiopathy—Topotecan—cervical cancer	0.00166	0.0129	CcSEcCtD
Clofarabine—Immune system disorder—Topotecan—cervical cancer	0.00165	0.0129	CcSEcCtD
Clofarabine—Mediastinal disorder—Topotecan—cervical cancer	0.00165	0.0129	CcSEcCtD
Clofarabine—Chills—Topotecan—cervical cancer	0.00164	0.0128	CcSEcCtD
Clofarabine—Alopecia—Topotecan—cervical cancer	0.00162	0.0126	CcSEcCtD
Clofarabine—ABCG2—female gonad—cervical cancer	0.0016	0.00896	CbGeAlD
Clofarabine—Malnutrition—Topotecan—cervical cancer	0.00159	0.0124	CcSEcCtD
Clofarabine—ABCG2—vagina—cervical cancer	0.00159	0.0089	CbGeAlD
Clofarabine—Back pain—Topotecan—cervical cancer	0.00154	0.012	CcSEcCtD
Clofarabine—RRM1—E2F transcription factor network—YY1—cervical cancer	0.00151	0.118	CbGpPWpGaD
Clofarabine—Anaemia—Topotecan—cervical cancer	0.00147	0.0115	CcSEcCtD
Clofarabine—Leukopenia—Topotecan—cervical cancer	0.00143	0.0111	CcSEcCtD
Clofarabine—Cough—Topotecan—cervical cancer	0.00139	0.0108	CcSEcCtD
Clofarabine—Arthralgia—Topotecan—cervical cancer	0.00136	0.0106	CcSEcCtD
Clofarabine—Myalgia—Topotecan—cervical cancer	0.00136	0.0106	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00135	0.0105	CcSEcCtD
Clofarabine—Infection—Topotecan—cervical cancer	0.00129	0.0101	CcSEcCtD
Clofarabine—Nervous system disorder—Topotecan—cervical cancer	0.00128	0.00994	CcSEcCtD
Clofarabine—Thrombocytopenia—Topotecan—cervical cancer	0.00127	0.00992	CcSEcCtD
Clofarabine—Skin disorder—Topotecan—cervical cancer	0.00126	0.00985	CcSEcCtD
Clofarabine—Hyperhidrosis—Topotecan—cervical cancer	0.00126	0.0098	CcSEcCtD
Clofarabine—RRM2—E2F transcription factor network—YY1—cervical cancer	0.00124	0.0969	CbGpPWpGaD
Clofarabine—Anorexia—Topotecan—cervical cancer	0.00124	0.00966	CcSEcCtD
Clofarabine—RRM1—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00122	0.095	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00119	0.00924	CcSEcCtD
Clofarabine—Paraesthesia—Topotecan—cervical cancer	0.00117	0.0091	CcSEcCtD
Clofarabine—Dyspnoea—Topotecan—cervical cancer	0.00116	0.00904	CcSEcCtD
Clofarabine—Decreased appetite—Topotecan—cervical cancer	0.00113	0.00881	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Topotecan—cervical cancer	0.00112	0.00875	CcSEcCtD
Clofarabine—Fatigue—Topotecan—cervical cancer	0.00112	0.00874	CcSEcCtD
Clofarabine—Pain—Topotecan—cervical cancer	0.00111	0.00867	CcSEcCtD
Clofarabine—Feeling abnormal—Topotecan—cervical cancer	0.00107	0.00835	CcSEcCtD
Clofarabine—Gastrointestinal pain—Topotecan—cervical cancer	0.00106	0.00829	CcSEcCtD
Clofarabine—ABCG2—lymph node—cervical cancer	0.00103	0.00576	CbGeAlD
Clofarabine—Body temperature increased—Topotecan—cervical cancer	0.00103	0.00801	CcSEcCtD
Clofarabine—Abdominal pain—Topotecan—cervical cancer	0.00103	0.00801	CcSEcCtD
Clofarabine—RRM2—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.001	0.0782	CbGpPWpGaD
Clofarabine—Hypersensitivity—Topotecan—cervical cancer	0.000959	0.00747	CcSEcCtD
Clofarabine—Asthenia—Topotecan—cervical cancer	0.000934	0.00727	CcSEcCtD
Clofarabine—Pruritus—Topotecan—cervical cancer	0.000921	0.00717	CcSEcCtD
Clofarabine—Diarrhoea—Topotecan—cervical cancer	0.00089	0.00694	CcSEcCtD
Clofarabine—Dizziness—Topotecan—cervical cancer	0.000861	0.0067	CcSEcCtD
Clofarabine—RRM1—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000851	0.0664	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—YY1—cervical cancer	0.000849	0.0663	CbGpPWpGaD
Clofarabine—Vomiting—Topotecan—cervical cancer	0.000827	0.00644	CcSEcCtD
Clofarabine—Rash—Topotecan—cervical cancer	0.000821	0.00639	CcSEcCtD
Clofarabine—Dermatitis—Topotecan—cervical cancer	0.00082	0.00639	CcSEcCtD
Clofarabine—Headache—Topotecan—cervical cancer	0.000815	0.00635	CcSEcCtD
Clofarabine—Nausea—Topotecan—cervical cancer	0.000773	0.00602	CcSEcCtD
Clofarabine—RRM2—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000701	0.0547	CbGpPWpGaD
Clofarabine—POLA1—Extension of Telomeres—TERT—cervical cancer	0.00053	0.0414	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000438	0.0342	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000375	0.0293	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000371	0.029	CbGpPWpGaD
Clofarabine—RRM1—Fluoropyrimidine Activity—TP53—cervical cancer	0.000323	0.0252	CbGpPWpGaD
Clofarabine—RRM2—Fluoropyrimidine Activity—TP53—cervical cancer	0.000266	0.0208	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000262	0.0205	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000247	0.0193	CbGpPWpGaD
Clofarabine—POLA1—Telomere Maintenance—TERT—cervical cancer	0.00024	0.0188	CbGpPWpGaD
Clofarabine—POLA1—Chromosome Maintenance—TERT—cervical cancer	0.0002	0.0156	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000164	0.0128	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.00015	0.0117	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	0.000149	0.0116	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000124	0.00966	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	0.000123	0.00957	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000119	0.00931	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	0.000115	0.00894	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—cervical cancer	9.96e-05	0.00777	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CA9—cervical cancer	9.58e-05	0.00747	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	9.45e-05	0.00738	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	9.21e-05	0.00719	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	8.38e-05	0.00654	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	7.94e-05	0.00619	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CA9—cervical cancer	7.89e-05	0.00616	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TERT—cervical cancer	7.43e-05	0.0058	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CA9—cervical cancer	7.37e-05	0.00575	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	6.97e-05	0.00544	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	6.72e-05	0.00524	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	5.32e-05	0.00415	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TERT—cervical cancer	5.08e-05	0.00397	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	4.47e-05	0.00349	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—MTHFR—cervical cancer	3.89e-05	0.00303	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—MTHFR—cervical cancer	3.2e-05	0.0025	CbGpPWpGaD
Clofarabine—DCK—Metabolism—MTHFR—cervical cancer	2.99e-05	0.00233	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CA9—cervical cancer	2.95e-05	0.0023	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—cervical cancer	2.83e-05	0.00221	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—cervical cancer	1.93e-05	0.00151	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—MTHFR—cervical cancer	1.2e-05	0.000934	CbGpPWpGaD
